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Hepatocyte growth factor gene therapy retards the progression Hepatocyte growth factor (HGF) is now well known
of chronic obstructive nephropathy. as a cytokine with numerous functions in diverse cell
Background. Unilateral ureteral obstruction (UUO) is char- survival and tissue regeneration [1–5]. It has been sug-acterized by progressive tubular atrophy and interstitial fibro-
gested that HGF acts as a cell survival factor by inhibitingsis. Rupture of the balance between cell proliferation and apo-
apoptosis in various cells [6–8]. The mediating ability toptosis plays a critical role in renal atrophy. Hepatocyte growth
factor (HGF) is a cytokine function on cell survival and tissue differentiate the mesenchyme to epithelium or endothe-
regeneration. We studied the effects and possible mechanisms lium is believed to be the pivotal function among the
of HGF gene therapy on tubular cell survival and anti-fibrosis pleiotropic roles of HGF [3]. Moreover, HGF also is con-in chronic obstructed nephropathy.
sidered to be a major determinant of whether the epithe-Methods. An in vivo transfection procedure of repeatedly
lium remains in a quiescent and mature state or shiftstransducing skeletal muscles with the HGF gene using lipo-
somes containing the hemagglutinating virus of Japan (HVJ to a proliferative and migratory state associated with
liposome) was tested on UUO rats. Expression of HGF and development and tissue repair [3]. Under normal condi-
c-Met were examined by in situ hybridization, ELISA, or im- tions, liver, kidney, and spleen produce low amounts ofmunohistochemical staining. Interstitial fibrosis and macro-
HGF. Following damage such as experimental ischemia,phage infiltration were evaluated by Masson’s Trichrome stain-
toxic injury or tissue loss, HGF and its receptor c-Meting, -smooth muscle actin and ED-1 immunostaining. Cell
survival indices including proliferating cell nuclear antigen increase systemically or locally, especially during the
(PCNA), Bcl-2, Bcl-xL and Bax were measured by immunohis- early stage after injury [9–12]. The fact that administra-
tochemistry and Western blots. Apoptosis was determined by tion of exogenous HGF ameliorated the injury whilethe TUNEL method.
neutralization of endogenous HGF accelerated the in-Results. After HVJ-HGF gene transfer, endogenous HGF
and c-Met were up-regulated in UUO kidneys. Renal fibrosis, jury allows the hypothesis that this up-regulation is bene-
macrophage infiltration and tubular atrophy were suppressed ficial. Therefore, research efforts have been focused on
both at day 14 and 28 after UUO (P  0.05 or 0.01). Tubular developing a feasible way of increasing the HGF level
cell proliferation was activated while apoptosis was inhibited,
in order to enhance its protective effects on damagedespecially at the late stage of UUO. Bcl-2 was enhanced in the
tissues [9, 13–17]. Compared with repeated injections ofHGF-transfected UUO rats, while no changes of Bcl-xL and
Bax were found. HGF protein or other methods, gene therapy is the best
Conclusions. In vivo HGF gene transfection retards the pro- for its efficiency and financial economy. Recently, a safe
gression of chronic obstructed nephropathy and protects tu- and efficient gene transfer strategy has been explored
bular cell survival in the long-term UUO model. Bcl-2 rather
[16–18]. We successfully reversed fibrotic lesions in ex-than Bcl-xL or Bax may contribute to the anti-apoptotic func-
perimental cirrhosis liver by using this strategy pre-tion of HGF.
viously [16]. Since kidney is another main target organ
of HGF, our current study tested whether the same pro-
tective effect can be realized in renal lesions via the same
HGF gene transfer method.
Abundant evidence suggests that onset and progres-
sion of renal failure are correlated tightly with tubuloin-Key words: HGF, c-Met, gene transfer, HVJ, renal fibrosis, tubular
atrophy, apoptosis, Bcl-2, Bax, Bcl-xL, unilateral ureteral obstruction. terstitial injury such as tubular atrophy, interstitial fibro-
sis and macrophage infiltration [19–24]. The unilateralReceived for publication October 8, 2001
ureteral obstruction (UUO) model, a well-established ani-and in revised form April 5, 2002
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It has been proposed that abnormal and increased apo- with the criteria outlined in the “Guide for the Care and
Use of Laboratory Animals” prepared by the Nationalptosis may participate in the progression of tubular atro-
phy in chronic obstructive uropathy [25]. Meanwhile, Academy of Science.
Unilateral ureteral obstructed rats were randomly sep-rupture of the balance between cell proliferation and
apoptosis has been demonstrated to play a critical role arated into two groups. The treated group received repet-
itive intramuscular injections of HVJ liposomes contain-in the pathogenesis and evolution of chronic obstructive
uropathy [26, 27]. ing pUC-SR/HGF as previously described [16]. Briefly,
HGF-HVJ-liposome treated UUO rats were injected inAlthough it is well accepted that HGF can protect
diverse cells from apoptosis, the mechanism remains un- their thigh muscles once a week (started immediately after
the UUO operation) with HVJ-liposomes containing 800certain [25]. Yamamoto et al claimed that the anti-apo-
ptotic mechanisms of HGF in hypoxia-induced endothe- g of pUC-SR/HGF, while the untreated group was
injected with BSS (balanced salt solution). Six rats oflial cell death largely depend on Bcl-2, but not Bcl-xL
and Bax [28]. On the contrary, Liu suggested that the each group were sacrificed at days 14 and 28 after the
UUO operation, respectively. Three rats each were sacri-anti-apoptotic effect of HGF in renal epithelial cells is
mediated by duel mechanisms: inactivating the pro-apo- ficed at 14 and 28 days after the sham operation.
ptotic protein Bax and stimulating the expression of anti-
In situ hybridizationapoptotic Bcl-xL [29]. The common aspect of these two
in vitro experiments is that HGF plays its anti-apoptotic For in situ hybridization, freshly dissected kidney tis-
sues were covered with Tissue-Tek OCT compound androle by regulating Bcl-2 family members. To our knowl-
edge, no study has examined this topic after in vivo HGF then quickly frozen. Frozen sections (6 to 8 m thick)
were cut and fixed with 4% paraformaldehyde in 0.1transfection in the UUO model.
The renotropic biochemical activation of HGF, espe- mol/L phosphate buffer (pH 7.2). Each fragment of rat
HGF cDNA (1536 to 2009) xx and c-Met cDNA (2661-cially on apoptosis, intrigued us, and this study was im-
plemented to determine whether HGF gene transfer 3469) xx was subcloned into Bluescript I KS () plasmid
(Stratagene, La Jolla, CA, USA), and complementarycould inhibit renal fibrosis and modulate the balance of
cell proliferation and apoptosis in chronic obstructive RNA probes were prepared by using a DIG RNA Label-
ing Kit (Boehringer Mannheim Biochemica, Mannheim,nephropathy. Although the UUO model has been stud-
ied prevalently, most researchers ended their observa- Germany) according to the manufacturer’s instructions.
Hybridization was performed at 50C for 16 hours, andtion at one week or two weeks after the obstruction. To
determine the effect of HGF gene therapy on the long- signals were visualized with a Dako Gen Point kit using
the horseradish peroxidase (HRP)-conjugated anti-digoxi-term or end-stage obstructed kidney was the main pur-
pose of this study. genin antibody (Dako).
Morphology and immunohistochemistry
METHODS
Kidney tissues for the histological study were fixed
Preparation of HVJ-liposomes with pUC-SR/HGF with 10% formalin (pH 7.4) and embedded in paraffin.
Sections (2 m thick) were cut, and stained with Mas-Human HGF cDNA (2.2 kb) was subcloned into the
NotI and NotI sites of the pUC-SR expression vector, son’s trichrome to evaluate the fibrosis of cortical inter-
stitium. Ten nonoverlapping, randomly selected 400and the resulting plasmid was designated as pUC-SR/
HGF. The hemagglutinating virus of Japan (HVJ)-artificial fields of each slide were analyzed with a standard point-
counting method [31, 32] by two observers who were un-viral envelope (AVE) liposomes containing pUC-SR/
HGF were constituted as previously described [16, 30]. aware of the experiment protocol. The microscopic fields
containing glomeruli and large vessels were excluded.
Animal experiment and gene transfection The averaged scores of 10 fields per slide were recorded.
Periodic acid-Schiff (PAS) staining was performed forThirty 5-week-old male Sprague-Dawley rats (SCL, Ha-
mamatsu, Japan) weighing 150 to 180 g were subjected the assessment of tubular atrophy. Atrophic tubules were
identified by the thickened tubular basement membranesto complete UUO or sham operation. Briefly, under
anesthesia with sodium pentobarbital (50 mg/kg body [33] and were graded on a scale from 0 to 3 according
to the percentage of involved tubules: 0  no involvedweight), the left ureter was cut after the two-point liga-
tion between the bladder and the renal pelvis. For sham- tubules; 1  less than 30%; 2  30% to 60%; 3  more
than 60% atrophic tubules.operated rats, the ureter was mobilized but not ligated.
All rats were free to drink water and eat standard labora- For immunohistochemistry, sections (2m thick) were
heated in a target retrieval solution (pH 6.0; Dako) fortory rat chow. All of the experiment procedures were
approved by the Animal Care Committee of Hyogo Col- 6 to 10 minutes at 115C or 121C with an autoclave
to facilitate antigen retrieval. Endogeneous peroxidaselage of Medicine, and were performed in accordance
Gao et al: HGF gene therapy on long-term UUO rat1240
activity was blocked by 1% H2O2 in methonal for 20 mouse anti--SMA monoclonal antibody (1:200); mouse
anti-PCNA monoclonal antibody (2.5 g/mL), mouseminutes. The sections were then incubated with the fol-
lowing primary antibodies overnight at 4C: mouse anti Bcl-2 monoclonal antibody (1:200), rabbit anti
Bcl-xL polyclonal antibody (1:200) and rabbit anti Baxmonoclonal anti-c-Met antibody (1:100; Santa Cruz Bio-
technology, Santa Cruz, CA, USA); mouse anti rat ED-1 polyclonal antibody (1:200). After washing, the mem-
branes were reacted with HRP-conjugated goat anti-antibody (1:100; Serotec, Oxford, UK); mouse anti-
-smooth muscle actin (anti--SMA) monoclonal anti- mouse or anti-rabbit IgG at room temperature for 30
minutes. After transferring the membranes to VECTA-body (1:50; Novo Castra, Newcastle, UK); mouse mono-
clonal anti-proliferating cell nuclear antigen (PCNA) STAIN ABC reagent (Vector Labs., Burlingame, CA,
USA) for 30 minutes at room temperature, bound anti-antibody (1:50; Oncogene, Calbiochem, Cambridge, UK);
mouse monoclonal anti-Bcl-2 antibody (1:50; Santa bodies were visualized by DAB substrate.
Cruz); rabbit polyclonal anti-Bcl-xL antibody (1:100;
ELISA for HGFSanta Cruz); rabbit polyclonal anti Bax antibody (1:100;
Santa Cruz). After washing, the corresponding second- To measure the rat HGF protein level in kidneys,
renal tissues were homogenized in the HGF extractionary antibodies (Envision, peroxidase, mouse or rab-
bit; Dako) were added to each slide for a 30-minute buffer (Institute of Immunology, Tokyo, Japan) and cen-
trifuged at 15,000 rpm for 30 minutes at 4C. Rat HGFincubation at room temperature. All the sections were
developed with diaminobenzidine tetrahydrochloride and human HGF in plasma were measured by using com-
mercial enzyme-linked immunosorbent assay (ELISA)(DAB) substrate and counterstained with hematoxylin.
The ED-1 positive cells and PCNA positive cells were kits (Institute of Immunology, Tokyo, Japan) following
the manufacturer’s instructions. The rat HGF ELISAcalculated under high magnification (400) of 20 ran-
domly selected cortical fields per section. The same system specifically detects rat HGF but not human HGF,
point-counting method was used for the other analyses and vice versa.
of immunohistochemical results.
Statistical analyses
Identification of apoptosis Results are expressed as mean	 SD. Statistical differ-
Apoptotic nuclei were detected by TUNEL technique ence was assessed by the unpaired two-tailed Student
using the in situ apoptosis detection kit (Takara Shuzou) t test or Mann-Whitney U test. P  0.05 was considered
according to the manufacturer’s instructions. Briefly, de- significant.
paraffinized sections were incubated with 10 g/mL pro-
teinase K at room temperature for 15 minutes to enable
RESULTSpenetration of TdT into the section for even incorpoation
Data from sham rats did not show any difference be-of nucleotides. Sections were incubated with terminal
tween days 14 and 28 post-operation, and therefore,deoxyribonucleotide transferase and biotin-labeled dUTP
three animals of each group were pooled into one groupat 37C for 60 minutes. After washing, sections were fur-
as the normal control. No changes in body weight andther incubated with the HRP conjugated streptavidin for
general condition were observed among the three groups30 minutes at 37C, and then the biotinylated dUTP was
throughout the duration of the experiment.visualized using DAB. The number of TUNEL-positive
cells in 20 nonoverlapping fields (200) of each section
Expression of HGF and its receptor c-Met afterwere averaged. The average of each of six separate kid-
HGF gene transfectionneys was, in turn, averaged as mean 	 SD.
A sustained level of human HGF (0.5 to 1 ng/dL) in
Western blotting analysis the circulation of HGF-HVJ liposome transfected rats
was detected as the same pattern as previously describedKidney tissues were homogenized in RIPA buffer [1%
[16]. Plasma levels of rat HGF were increased signifi-NP40, 0.5% sodium deoxycholate, 0.1% sodium do-
cantly after HGF-HVJ liposome transfection (0.17 	decylsulfate, 100 g/mL phenylmethylsulfonyl fluoride
0.03 vs. 0.23	 0.02 ng/mL, P 0.05 at day 14 and 0.16	(PMSF), 30 L/mL aprotinin, 1 mmol/L sodium ortho-
0.018 vs. 0.24 	 0.03 ng/mL, P  0.05 at day 28 post-vanadate in phosphate-buffered saline (PBS) pH 7.4]
operation).on ice. After centrifugation at 10,000  g at 4C for 20
The expression and histologic localization of endoge-minutes, the supernatants were collected. Aliquots of
nous HGF and c-Met mRNA in kidneys from differentsamples (60 g/lane) were resolved by 10% sodium do-
groups were evaluated by in situ hybridization. In shamdecylsulfate-polyacrylamide gel electrophoresis (SDS-
rats, weak but extensive hybrid signals of Both HGF andPAGE) and transferred to polyvinylidine difluoride
c-Met were localized in tubular epithelial cells, intersti-(PVDF) membranes. The membranes were then probed
with the following primary antibodies at 4C overnight: tial cells, glomerular endothelial cells and Bowman’s cap-
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sule. After ureteral ligation, expression of HGF and tration is obviously less common in HGF-injected UUO
rats compared with BSS-injected UUO rats (Fig. 2B).c-Met was increased in the tubulointerstitium while glo-
merular signals remained the same. HGF was mainly
Effect on tubular proliferation and apoptosis inlocated in interstitium and Bowman’s capsule, c-Met was
HGF transfected ratsmainly expressed in the tubular epithelial cells. Further-
To investigate whether the HGF gene transfectionmore, compared with the untreated UUO kidney, endog-
could moderate the imbalance between tubular cell pro-enous HGF and c-Met mRNA were markedly up-regu-
liferation and apoptosis in post-obstructed kidneys, welated after the HGF transfection (Fig. 1A). Negative
examined the changes of proliferating tubular cells, iden-results were observed by probed the sections with the
tified as PCNA-positive nuclei and apoptotic bodies,corresponding sense probes (data not shown).
marked as an in situ end-labeled DNA fragment withUsing ELISA or immunohistochemistry, an increasing
the TUNEL method.tendency for HGF and c-Met protein in HGF transfected
Compared with sham rats, proliferating tubular cellsUUO kidneys was demonstrated. c-Met was positively
were increased significantly throughout the whole ex-stained in tubular epithelial cells, especially in those tu-
perimental period, though the degree of proliferationbules showing activated proliferation (Fig. 1 B, C).
showed a gradual tendency for weakness in late-stage
UUO kidney. After HGF gene transfection, the prolifer-Suppression of renal fibrosis, macrophage infiltration
ative activity was enhanced by 1.5- to twofold in eachand tubular atrophy by HGF gene transfer
time course. Consistent with the immunohistochemicalIt is well known that UUO renal histology displays a
findings, renal PCNA blotting bands were obviouslyspectrum of changes including tubular dilation and inter-
stronger after HGF-HVJ-liposome treatment (Fig. 3A).stitial edema in the early stage, and tubular atrophy and
To determine whether HGF can protect renal tubularinterstitial fibrosis in the later phase [26]. Compared with
epithelial cells from apoptosis, the number of tubularuntreated obstructed kidneys, HGF transfected UUO
apoptotic bodies were counted and the results are sum-kidneys at the same time course post-operation pre-
marized in Figure 3B. In parallel with the fibrosis-relatedsented fewer chronic features, namely, less tubular atro-
index described earlier, tubular apoptosis was activatedphy and less interstitial fibrosis. Interstitial collagen accu-
after UUO operation and progressively increased duringmulated more abundantly in the late-stage of untreated
the entire four-week course. Although the absolute num-UUO (Fig. 2A). The fibrogenetic indicator, -SMA was
ber of apoptotic bodies in tubule at day 14 did not showincreased in the exactly same pattern with the fibrosis
a statistical difference between the two groups, consider-
index in obstructed kidneys. Administration of HGF-
ing the increased number of tubular cells caused by the
HVJ liposome successfully suppressed the activation of more active proliferation in HGF-treated rats, the anti-
fibroblasts, especially in the end-stage obstructed kid- apoptotic effect is obvious. Tubular apoptosis was sup-
neys (Fig. 2C). pressed by 40% in transfected rats at day 28, which posi-
Tubular atrophy progressed in a time-dependent man- tively confirms our previous hypothesis. Histologically,
ner after the UUO operation. In parallel with the intersti- the apoptotic bodies were mainly observed in atrophied
tial expansion, tubular atrophy became the dominant tubular cells (Fig. 3B).
pathologic change of end-stage of UUO kidneys. HGF
gene transfection obviously retarded this progression as Regulation of renal Bcl-2, Bax and Bcl-xL expression
shown in Figure 2D. by HGF gene therapy
The interstitial macrophage infiltration was further de- After determining that HGF gene therapy could suc-
tected by the change of ED-1 positive cells in renal cor- cessfully inhibit apoptosis in the obstructed kidney, we
tex. Likewise, the infiltration of macrophages was signif- searched for the possible mechanism. The expression of
icantly increased in post-obstructed kidneys, but with a Bcl-2, Bcl-xL and Bax, the three main oncogenes from
different pattern from fibrotic hyperplasia; it peaked at the well-known apoptosis-regulated Bcl-2 family, were
the two-week course and decreased afterwards. In HGF- detected. In normal kidneys, immunodetectable Bcl-2
transfected UUO rats, an increase of interstitial macro- protein expressed at a relatively low level, which was
phage infiltration also was detected in the same pattern, mainly distributed in distal convoluted tubules and inter-
but the degree of damage was successfully inhibited (Fig. stitium (data not shown). After the UUO operation,
2B). By histological examination, ED-1 stained cells Bcl-2 positive staining in tubules increased at day 14 and
were located particularly around the atrophied tubules, returned to the normal level at day 28. The degree of
in agreement with other studies [15]. Moreover, we this up-regulation became much more significant after
found that in the late-stage UUO kidney, macrophages HGF transfection (Fig. 4A). To confirm this result, West-
accumulated mainly within the atrophied tubules rather ern blotting analysis was performed, and the result was
consistent in the UUO kidney (Fig. 4B).than in the interstitium. This tubular macrophage infil-
Fig. 1. Local up-regulation of endogenous
hepatocyte growth factor (HGF) and c-Met
in HGF transfected, unilateral ureteral ob-
structed (UUO) kidneys. Sections or renal ly-
sates were obtained on day 14 after sham or
UUO operation (treated and untreated group).
An increased expression of HGF (400) and
c-Met (200) mRNA by HGF transfer was
detected by in situ hybridization. All the show-
ing sections were attached on one slide for one
probe to strictly ensure the same experimental
condition (A). An increase tendency of renal
endogenous HGF protein level by ELISA (B)
and c-Met protein level by immunohistochem-
ical staining (200; C ) in HGF-treated UUO
kidneys. †P  0.073 vs. HGF-treated; ††P 
0.078 vs. balanced salt solution (BSS)-treated.
Fig. 3. (A) Active effect of HGF gene trans-
fection on renal tubular proliferation by
PCNA expression of immunohistochemical
stain (400) and Western blotting (total pro-
tein was pooled from 6 rats per group.). Sham
rat kidneys (lane 1); kidneys from UUO rats:
2 weeks treated with HGF (lane 2) or BSS
(lane 3), 4 weeks treated with HGF (lane 4)
or BSS (lane 5). (B) Protective effect of HGF
gene transfection on renal tubular apoptosis
by TUNEL staining (200). *P 0.05, **P
0.01, vs. sham group; #P 0.05, NS: P 
 0.05,
HGF-treated group vs. BSS-treated group.
Data are expressed as mean 	 SD, N  6
for each group. Symbols are: () Sham; ( )
HGF-treated; () BSS-treated.
Fig. 2. Suppressive effects of HGF gene transfection on fibrosis, macrophage infiltration and tubular atrophy in UUO kidney. (A) Morphological
changes in UUO kidneys from each group and semiquantitation of relative interstitial volume by Masson’s trichrome stain. (B) Changes in
macrophage infiltration by ED-1 staining. (C ) Changes in fibrogenetic activity marked by -SMA immunostaining and Western blotting (total
protein was pooled from 6 rats per group.). Sham rat kidneys (lane 1); kidneys from UUO rats: 2 weeks treated with HGF (lane 2) or BSS (lane
3), 4 weeks treated with HGF (lane 4) or BSS (lane 5). (D) Semiquantitation of relative tubular atrophy analysis. *P  0.05, **P  0.01, vs. sham
group; #P  0.05, ##P  0.01, HGF-treated group vs. BSS-treated group. Data are expressed as mean 	 SD; N  6 for each group. Symbols are:
() Sham; ( ) HGF-treated; () BSS-treated (magnification A-D, 200).
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Fig. 4. Up-regulation of Bcl-2 expression in UUO kidney by HGF gene transfer. (A) Distribution and semi-quantitation of immunohistochemical
detectable Bcl-2 protein (400) in UUO kidneys from each group. Bcl-2 positive staining were mainly observed in deformed tubules. *P  0.05,
**P  0.01, NS: P 
 0.05, vs. sham group; #P  0.05, HGF-treated group vs. BSS-treated. Data are expressed as mean 	 SD, N  6 for each
group. Symbols are: () Sham; ( ) HGF-treated; () BSS-treated. (B) Renal Bcl-2 protein probed by Western blotting method. Total protein
was pooled from 6 rats per group. Sham rat kidneys (lane 1), kidneys from UUO rats: 2 weeks treated with HGF (lane 2) or BSS (lane 3), 4
weeks treated with HGF (lane 4) or BSS (lane 5).
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Fig. 5. Expressions of Bax and Bcl-xL in UUO kidneys by HGF-treated remains unchanged. (A) Renal Bax protein detected by immunohistochemi-
cal staining (200) and Western blotting. (B) Renal Bcl-xL protein detected by immunohistochemical staining (400) and Western blotting. **P 
0.01, vs. sham group; NS: P 
 0.05, HGF-treated group vs. BSS-treated group. Data are expressed as mean 	 SD, N  6 for each group. Symbols
are: ( ) Sham; ( ) HGF-treated; () BSS-treated. Sham rat kidneys (lane 1), kidneys from UUO rats; 2 weeks treated with HGF (lane 2) or
BSS (lane 3), and 4 weeks treated with HGF (lane 4) or BSS (lane 5).
Bcl-xL and Bax protein expressions also were exam- of Bcl-xL protein expression in the kidneys between the
ined to determine whether there was any influence by HGF-injected and BSS-injected UUO rats.
HGF transfection. As described in Fig. 5A, immunoreac- To investigate whether this in vivo HGF-HVJ lipo-
tive Bax was distributed mainly in tubules, and was de- some transfection method influenced other organs, we
tected more extensively than immunodetectable Bcl-2. examined the brain, liver, heart, lung, spleen and injec-
Unexpectedly, we found that Bax protein was down- tion muscles with HE staining, and found no pathological
regulated on day 28 compared with day 14 despite that changes (data not shown).
apoptosis was more active in the former stage. One possi-
ble explanation is the loss of tubular cells in the late-
DISCUSSIONstage of UUO. HGF treatment did not seem to affect
The fact that endogenous HGF increased significantlyBax expression in the UUO kidney. Immunodetectable
after transduction of the HGF gene into skeletal muscleBcl-xL protein was located mainly in the distal tubules
has been proven in vivo previously [16, 34]. Our studyof sham rats (data not shown). After the UUO operation,
further demonstrates the local up-regulation of rat HGFBcl-xL expression was detected especially in deformed tu-
bules (Fig. 5B). We failed to find any significant changes and its sole receptor c-Met gene in UUO kidneys by the
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same gene transfection method. However, the mecha- course, but support their findings that tubular apoptosis
rather than proliferation takes the dominant position innism for how an exogenous HGF gene therapy can cause
a burst of endogenous HGF production remains unclear. the late-stage of chronic obstructive nephropathy. Mean-
while, we found that HGF gene transduction successfullyAs described in the Results section, c-Met mRNA in-
creased more drastically than HGF itself after HGF retarded the progress of this imbalance: tubular cell pro-
liferation was still active at day 14 or even day 28 aftertransfection, an observation consistent with the finding in
DMN-induced liver cirrhosis rat treated with HGF-HVJ the UUO operation. Cell death and cell proliferation
are obligatory companions [38], which helped us to un-liposomes [16]. Some in vitro experiments also demon-
strated that HGF could target the induction of its recep- derstand why no significant difference on tubular apo-
ptosis was found between the two groups at day 14. Ittor in diverse cells [8, 35]. The activation and amplifica-
tion of this ligand-receptor pair of signaling systems is not surprising that apoptosis abundantly present in
tubules leads to the destruction of the tubulointerstitialremains unclear to date. However, the induction of c-Met
expression in renal mouse renal epithelial cells was proven microenvironment, resulting in activation of myofibro-
blasts and hence extracellular membrane (ECM) accu-to be specific to HGF stimulation [8]. Binding of HGF
to c-Met causes receptor homodimerization, autophos- mulation. Any intervention that can block tubular apo-
ptosis may be effective in the prevention of interstitialphorylation, and activation of tyrosine kinase activity,
which in turn activates complex downstream signaling fibrosis, and thus may retard the progression of chronic
renal failure.cascades [36, 37]. Thus, we speculate that transduction
of exogenous HGF first up-regulates its receptor c-Met, Given that HGF gene therapy can benefit tubular cell
survival in UUO, the mechanism should be paid morewhich further triggers the increase of endogenous HGF.
This hypothesis requires further investigation before it attention. The balance between cellular differentiation
and apoptosis determines the fate of cells. Many cyto-can be confirmed or rejected.
Renal tubulointerstitial damage, including interstitial kines or factors are suggested to be involved in this
process, and among them one group of protooncogenesfibrosis, tubular atrophy and macrophage infiltration,
is the main cause of end-stage renal failure, regardless named the Bcl-2 family is more notable. Intrinsic regula-
tors of apoptosis in mammalian cells are mainly recog-of the primary etiology of renal disease. Macrophage
infiltration of the interstitium and increased numbers of nized as the Bcl-2 family [39–41]. Overexpression of
Bcl-2 protects cells from programed cell death resultingactivated fibroblasts accompany interstitial matrix accu-
mulation. Recruitment of macrophages was obviously from many stimuli [40]. On the other hand, during the
induction process for metanephric blastema, up-regula-correlated with tubular atrophy in our results and those
of other researches [15]. Therefore, suppressing macro- tion of Bcl-2 occurs after the commitment of the undiffer-
entiated mescenchyme to epithelial differentiation. Aphage infiltration makes it possible to reduce renal inter-
stitial fibrosis and tubular atrophy. The popularity of conclusion from this observation is that, of the popula-
tion of mescenchyme cells that are committed to epithe-tubulointerstitial macrophage in the UUO kidney was
significantly attenuated by HGF transduction. Likewise, lial differentiation, only those cells expressing Bcl-2 sub-
sequently differentiate into renal epithelium. Therefore,the expansion of the renal interstitium and the activa-
tion of fibroblasts after UUO were partly but signifi- it appears as if the survival advantage imparted by Bcl-2
gene expression may be necessary for the conversion ofcantly suppressed after HVJ-HGF liposome delivery.
The mechanism of the suppressive function of HGF on the uninduced mesenchyme into the mature nephron
[42]. Based on the above background knowledge, somemacrophage infiltration and interstitial fibrosis was not
included in this study and needs further research. researchers have focused on determining whether or how
HGF regulates Bcl-2 family in protecting diverse cells.Our results emphasize the influence of HGF gene ther-
apy on cell proliferation and apoptosis in damaged tu- As mentioned earlier, the conclusions have conflicted
[27, 28]. Most recently, Xin et al demonstrated that HGFbules, especially in the late-stage of chronic obstructive
nephropathy. Tubular apoptosis mediates tubular atro- acted in concert with VEGF to promote human endothe-
lial cell survival and tubulogenesis in 3-D type I collagenphy and renal weight loss in the UUO model [25, 26].
After a 90-day observation period after UUO operation, gels and increased neovascularization in rat corneal cells.
These synergistic effects on endothelial survival wereTruong et al claimed that a remarkable inverse relation-
ship of renal weight and the frequency of tubular cell suggested in correlation with greatly augmented mRNA
levels for the anti-apoptotic genes Bcl-2 and A1 [43].apoptosis exists between days 6 and 25, during which
period the magnitude of these changes reaches the maxi- Our data suggest that Bcl-2 is up-regulated in HGF-
transfected UUO rats, while Bax does not seem to bemum. On the contrary, the proliferative activity peaked
around one week postoperation and thereafter decreased influenced by HGF transfection. It is postulated that
Bcl-2 and Bax are a pair of homologous proteins havingdrastically to the control level [26]. Our data showed
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